| Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study E Majounie, AE Renton, K Mok, EGP Dopper, A Waite, S Rollinson, ... The Lancet Neurology 11 (4), 323-330, 2012 | 1306 | 2012 |
| The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous … V Farooq, PW Serruys, HM Garcia-Garcia, Y Zhang, CV Bourantas, ... Journal of the American College of Cardiology 61 (3), 282-294, 2013 | 335 | 2013 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 272 | 2018 |
| Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score V Farooq, Y Vergouwe, L Räber, P Vranckx, H Garcia-Garcia, R Diletti, ... European heart journal 33 (24), 3098-3104, 2012 | 195 | 2012 |
| Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective C Tamburino, A Latib, RJ Van Geuns, M Sabate, J Mehilli, T Gori, ... EuroIntervention 11 (1), 45-52, 2015 | 180 | 2015 |
| ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold … R Diletti, PW Serruys, V Farooq, K Sudhir, C Dorange, K Miquel-Hebert, ... American heart journal 164 (5), 654-663, 2012 | 160 | 2012 |
| Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary … V Farooq, PW Serruys, C Bourantas, P Vranckx, R Diletti, ... European heart journal 33 (24), 3105-3113, 2012 | 156 | 2012 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 153 | 2017 |
| Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study R Diletti, A Karanasos, T Muramatsu, S Nakatani, NM Van Mieghem, ... European heart journal 35 (12), 777-786, 2014 | 151 | 2014 |
| Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting A Franzone, E McFadden, S Leonardi, R Piccolo, P Vranckx, PW Serruys, ... Journal of the American College of Cardiology 74 (18), 2223-2234, 2019 | 122 | 2019 |
| Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice NM Van Mieghem, RM Van Der Boon, E Faqiri, R Diletti, C Schultz, ... JACC: Cardiovascular Interventions 6 (8), 867-875, 2013 | 119 | 2013 |
| Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience A Karanasos, N Van Mieghem, N van Ditzhuijzen, C Felix, J Daemen, ... Circulation: Cardiovascular Interventions 8 (5), e002369, 2015 | 113 | 2015 |
| Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential … V Farooq, PW Serruys, JH Heo, BD Gogas, Y Onuma, LE Perkins, R Diletti, ... JACC: Cardiovascular interventions 6 (5), 523-532, 2013 | 111 | 2013 |
| Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study K Masdjedi, LJC van Zandvoort, MM Balbi, FJH Gijsen, JMR Ligthart, ... EuroIntervention 16 (7), 591-599, 2020 | 110 | 2020 |
| Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen … R Diletti, V Farooq, C Girasis, C Bourantas, Y Onuma, JH Heo, BD Gogas, ... Heart 99 (2), 98-105, 2013 | 104 | 2013 |
| NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography S Brugaletta, HM Garcia-Garcia, PW Serruys, S De Boer, J Ligthart, ... JACC: Cardiovascular Imaging 4 (6), 647-655, 2011 | 104 | 2011 |
| Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography J Gomez-Lara, M Radu, S Brugaletta, V Farooq, R Diletti, Y Onuma, ... JACC: Cardiovascular Interventions 4 (9), 992-1001, 2011 | 100 | 2011 |
| Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study CV Bourantas, HM Garcia-Garcia, V Farooq, A Maehara, K Xu, ... JACC: Cardiovascular Imaging 6 (12), 1263-1272, 2013 | 90 | 2013 |
| Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound JN van der Sijde, A Karanasos, NS van Ditzhuijzen, T Okamura, ... European Heart Journal–Cardiovascular Imaging 18 (4), 467-474, 2017 | 87 | 2017 |
| Clinical characteristics and management of coronary artery perforations: a single‐center 11‐year experience and practical overview ME Lemmert, RJ van Bommel, R Diletti, JM Wilschut, PP de Jaegere, ... Journal of the American Heart Association 6 (9), e007049, 2017 | 84 | 2017 |
Salvatore BrugalettaHospital ClinicVerified email at clinic.cat
